Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VHT-200 Wound Treatment System

K-Number: K212121 · 2023-03-23

ApplicantVaporox, Inc.
Decision Date2023-03-23
Product CodeKPJ
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

VHT-200 Wound Treatment System is a medical device manufactured by Vaporox, Inc.. It received FDA 510(k) clearance on 2023-03-23 under approval number K212121. The device is classified under product code KPJ. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VHT-200 Wound Treatment System?

VHT-200 Wound Treatment System is a medical device that received FDA 510(k) clearance on 2023-03-23. It is manufactured by Vaporox, Inc.. The 510(k) number is K212121.

When was VHT-200 Wound Treatment System approved by the FDA?

VHT-200 Wound Treatment System received FDA 510(k) clearance on 2023-03-23, under approval number K212121.

What company makes VHT-200 Wound Treatment System?

VHT-200 Wound Treatment System is manufactured by Vaporox, Inc..

What is the FDA product code for VHT-200 Wound Treatment System?

The FDA product code for VHT-200 Wound Treatment System is KPJ.

Related Clinical Trials

NCT07614997 Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck NOT_YET_RECRUITING NCT05003843 BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis ACTIVE_NOT_RECRUITING NCT07499128 Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event ENROLLING_BY_INVITATION NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT05701917 DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis RECRUITING NCT07222787 Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes RECRUITING

Related PubMed Literature

PMID: 41251011 Effectivity of the Dehydrated Human Amnion/Chorion Membrane Allograft for Diabetic Foot Ulcers in Japan: A Case Series. International wound journal (2025) PMID: 40624966 Peptide-Enhanced Bioactive Hydrogel Combined with Photodynamic-Phage Synergistic Antibacterial Therapy System Accelerates Infected Wound Healing. Advanced healthcare materials (2025) PMID: 40258332 Chronic expanding hematoma following Gamma Knife irradiation for primary central nervous system lymphoma: illustrative case. Journal of neurosurgery. Case lessons (2025)

Other Devices by Vaporox, Inc.

K250188Wound Treatment System (VHT-200)

Related Devices (Code: KPJ)

K190742EPIFLO-28Neogenix, LLC Dba Ogenix K250188Wound Treatment System (VHT-200)Vaporox, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑